Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

AMATO, Marco Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.376
EU - Europa 3.466
AS - Asia 1.183
AF - Africa 61
SA - Sud America 16
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.370
IT - Italia 915
CN - Cina 827
FI - Finlandia 799
UA - Ucraina 523
IE - Irlanda 329
DE - Germania 283
SG - Singapore 177
GB - Regno Unito 163
SE - Svezia 103
RU - Federazione Russa 86
FR - Francia 72
CI - Costa d'Avorio 55
RO - Romania 55
BE - Belgio 53
TR - Turchia 45
IN - India 41
KR - Corea 35
NL - Olanda 15
CZ - Repubblica Ceca 14
CH - Svizzera 12
IR - Iran 11
PL - Polonia 11
GR - Grecia 10
BR - Brasile 9
HK - Hong Kong 7
TW - Taiwan 7
UZ - Uzbekistan 7
AT - Austria 6
LB - Libano 6
CA - Canada 5
ES - Italia 5
JP - Giappone 5
EG - Egitto 4
EU - Europa 4
PE - Perù 4
AU - Australia 3
BG - Bulgaria 3
CL - Cile 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
ID - Indonesia 2
IQ - Iraq 2
MK - Macedonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
TZ - Tanzania 2
BA - Bosnia-Erzegovina 1
CY - Cipro 1
DK - Danimarca 1
IL - Israele 1
KH - Cambogia 1
LT - Lituania 1
MX - Messico 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 12.111
Salva come PNG Salva come JPEG
Città #
Fairfield 923
Ashburn 619
Chandler 605
Woodbridge 485
Wilmington 479
Ann Arbor 458
Houston 419
Seattle 372
Jacksonville 334
Dublin 329
Cambridge 317
Medford 212
Palermo 186
Des Moines 160
Nanjing 159
Singapore 139
Princeton 136
Boardman 109
Dearborn 94
Tulsa 84
Altamura 82
New York 71
Shenyang 69
Jinan 66
San Diego 65
Beijing 60
Nanchang 56
Abidjan 55
Changsha 55
Brussels 53
Lawrence 53
Tianjin 51
Izmir 44
Hebei 41
Milan 36
Ningbo 36
Zhengzhou 36
Jiaxing 31
Phoenix 28
Kumar 27
Auburn Hills 26
Frankfurt 26
Falls Church 25
Guangzhou 25
London 24
Saint Petersburg 23
Taizhou 23
Verona 22
Hangzhou 21
Santa Clara 21
Seongnam 21
Venice 20
Taiyuan 18
Atlanta 17
Los Angeles 16
Bucheon-si 14
San Paolo di Civitate 14
Lanzhou 13
Brno 12
Haikou 12
Helsinki 10
Norwalk 10
Orange 10
Redwood City 10
Chicago 9
Durham 9
Düsseldorf 9
Kunming 9
Ludwigshafen am Rhein 9
Rome 9
Moscow 8
Munich 8
Tehran 8
Taipei 7
Washington 7
Fuzhou 6
Montegrotto Terme 6
Bremen 5
Hefei 5
Napoli 5
Pune 5
São Luís 5
Alicante 4
Bari 4
Den Haag 4
Edinburgh 4
Kilburn 4
Lima 4
Monreale 4
Sestri Levante 4
Albany 3
Catania 3
Central 3
Erice 3
Groningen 3
Padova 3
Pellezzano 3
Sofia 3
Stockholm 3
Tokyo 3
Totale 8.258
Salva come PNG Salva come JPEG
Nome #
Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory 218
Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. 193
The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome 177
Anaplastic Thyroid Carcinoma: A ceRNA Analysis Pointed to a Crosstalk between SOX2, TP53, and microRNA Biogenesis. 176
In vitro identification and characterization of CD133pos cancer stem-like cells in anaplastic thyroid carcinoma cell lines 174
BRAFV600E mutation, TIMP-1 up-regulation and NF-{kappa}B activation: closing the loop on the papillary thyroid cancer trilogy. 174
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease 171
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome 170
Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency 162
Visceral Adiposity Index (VAI) Is Predictive of an Altered Adipokine Profile in Patients with Type 2 Diabetes 162
Use of Glargine in Pregnant Women with Type 1 Diabetes Mellitus: A Case-Control Study 158
Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index 158
Serum miRNAs in women affected by hyperandrogenic polycystic ovary syndrome: the potential role of miR-155 as a biomarker for monitoring the estroprogestinic treatment 158
Fine-Needle Aspiration (FNAB) Molecular Analysis for the Diagnosis of Papillary Thyroid Carcinoma through BRAFv600E mutation and RET/PTC rearrangement 157
Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study 157
OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes. 156
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? 155
Visceral Adiposity Index Is Associated with Insulin Sensitivity and Adipocytokine Levels in Newly Diagnosed Acromegalic Patients. 154
Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. 151
BRAFV600E Mutation and p27kip1 Expression in Papillary Carcinomas of the Thyroid ≤1 cm and Their Paired Lymph Node Metastases 149
Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein. 147
The Metabolic Profile in Active Acromegaly is Gender-Specific. 146
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. 146
Development of a fuzzy expert system for the control of glycemia in type 1 diabetic patients 145
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction 138
Complete biochemical control and pituitary adenoma disappearance in a child with gigantism: efficacy of octreotide therapy 138
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. 134
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 134
Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. 132
Correlation between Severity of Growth Hormone Deficiency and Thyroid Metabolism and Effects of Long-Term Growth Hormone Treatment on Thyroid Function in Children with Idiopathic Growth Hormone Deficiency. 128
Relative Hypoleptinemia in poor controlled patients with Type 1 Diabetes 125
Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome. 124
Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome 123
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus. 121
Il c-peptide come marker principale nella storia naturale del Diabete tipo 1: ruolo della funzione b-cellulare pancreatica nelle complicanze 119
Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA). 119
Phenotyping of type 2 diabetes mellitus at onset on the basis of fasting incretin tone: Results of a two-step cluster analysis 117
Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment. 116
Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency. 112
Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations 110
Clinical indications and proper use of Visceral Adiposity Index. 109
Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment 108
Cornea in acromegalic patients as a possible target of growth hormone action. 107
Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. 105
null 104
Clamp euglicemico iperinsulinemico e test al glucagone come utili strumenti di valutazione degli effetti metabolici della terapia sostitutiva con GH. 104
Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. 101
Valutazione dell'insulinoresistenza tramite un test pasto standard 98
Safety of glargine therapy during pregnancy in women with type 1 diabetes mellitus. 94
The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk. 94
Off-line control of the postprandial glycemia in type 1 diabetes patients by a fuzzy logic decision support 93
Espressione dei fattori di trascrizione di staminalità in cellule stromali (HASC) ottenute da tessuto adiposo viscerale e sottocutaneo 92
GH-suppression test in acromegaly: comparison between OGTT and chocolate test 91
Sviluppo di un sistema di supporto decisionale tipo Fuzzy per il controllo della glicemia post-prandiale nel diabete mellito tipo 1 91
THE CLINICAL ACTIVITY SCORE IN MANAGEMENT OF GRAVES’ OPHTHALMOPATHY: CORRELATION WITH ORBITAL MR IMAGING. 91
Body composition assessment for the definition of cardiometabolic risk. 90
The current version of the visceral adiposity index is not suitable for application in pediatric populations: comments on the article by Al-Daghri et al. 89
No effect of GH/IGF-1 excess on adrenal glands in acromegalic patients 87
Rotterdam consensus, NIH and EAS: comparison among the three different diagnostic criteria for the diagnosis of PCOS. 87
null 87
Leptina e adiponectina nella valutazione del compenso glicometabolico in corso di diabete mellito di tipo 1 normopeso. 86
Endocrine and pro-inflammatory activity of visceral (VAT) and subcutaneous (SAT) adipose tissue in morbidly obese patients with and without metabolic syndrome. 86
Insulin resistance and polycystic ovary syndrome. 85
Visceral Adiposity Index (VAI): A Reliable Indicator Of Visceral Fat Function Associated With Cardiometabolic Risk. 85
Changes in lipid profile and adipokine levels in GH deficient children during GH replacement therapy. 84
L’uso del hrTSH nel follow up del microcarcinoma tiroideo in pazienti sottoposti a tiroidectomia totale 83
Variabili cliniche nella casistica del policlinico di Palermo nell’ambito del registro dei tumori della tiroide in Sicilia: Età, sesso, autoimmunità, tipo, dimensionilesionali e coinvolgimento delle stazioni linfonodali della tiroide 82
Visceral Adiposity Index (VAI) as a simple indicator of “adipose tissue dysfunction” in patients with type 2 diabetes. 82
HYPERINSULINISM AND POLYCYSTIC OVARY SYNDROME (PCOS): ROLE OF INSULIN CLEARANCE. 82
Adrenal incidentaloma: a new contributing factor in metabolic syndrome 81
Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia. 80
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni contro regolatori. 79
BRAFV600E mutation and timp-1 hyper-expression in classical variants of papillary thyroid carcinoma (PTC). 79
Detection of BRAFv600E mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specimens. 78
Effetti della terapia combinata (OHA+Insulina) su una casistica ambulatoriale di pazienti affetti da NIDDM. 78
Neck liymph nodes in chronic autoimmune thyroiditis: the sonographic pattern. 78
Effetti di una terapia con glucocorticoidi ev ad alte dosi sull'oftalmopatia di Graves moderata-severa:uno studio caso-controllo 77
BRAFV660E mutation and Timp-1 hyper-expression in classical variants of papyllary thyroid carcinoma. 76
Variazioni plasmatiche del fattore di crescita insulino-simile (IGF-1) durante iperinsulinizzazione esogena (calmp euglicemico) in pazienti affetti da sindrome metabolica con e senza complicanze macrovascolari. 74
The adipose visceral dysfunction plays an important role in diabetes in Cushing disease. 74
Use of antiepileptic drugs in women with polycystic ovary syndrome 72
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni controregolatori: ruolo del GH 72
The use of rh-TSH in the follow-up of thyroid microcarcinoma after total thyroidectomy 71
Complete biochemical control and oituitary adenoma disappearance in a child with gigantism: efficay of octreotide therapy 70
Visceral Adipose function, insulin sensitivity and secretion in active acromegaly. 70
Polycistic ovary syndrome and antiepileptic drugs: a cross-sectional study 68
Low hrTSH-Tg levels in patients affected by papillary thyroid microcarcinoma are influenced by pre-surgery L-thyroxine therapy. 68
Marcatori di rischio diabetologico nella Sindrome dell’ovaio policistico (PCOS). 68
Adrenal incidentaloma: a new contributing factor in metabolic syndrome? 67
AlKam Metabolic Syndrome Study (AlkaMeSy Study): Studio di prevalenza sulla sindrome metabolica. 67
Prevalenza del cancro del colon e di altre neoplasie in una casistica ambulatoriale di soggetti affetti da diabete mellito tipo 2. 66
Detection of BRAFV600 mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specimens 65
Low Estradiol-to-Testosterone ratio is associated with low progesterone levels and atherogenic lipidic pattern in women with policystic ovary syndrome (PCOS). 65
Il c-peptide come marker principale nella storia naturale del Diabete di tipo 1: ruolo della funzione b-cellulare pancreatica nelle complicanze. 64
Utilizzo dell’insulina detemir in una casistica di donne affette da diabete tipo 1 in gravidanza: uno studio caso-controllo retrospettivo. 63
Utilizzo del Visceral Adiposity Index per l’identificazione di donne con sindrome iperandrogenica a rischio cardiometabolico. 63
Alte dosi di cabergolina migliorano i parametri metabolici in pazienti affetti da prolattinoma. 62
The relationship between metabolic syndrome and bone health: results of a retrospective gender specific female study. 62
La valutazione retinica mediante Tomografia a Coerenza Ottica (OCT) nel diabete mellito tipo 1. 61
INSULIN SECRETION AND SENSITIVITY DURING PASIREOTIDE TREATMENT IN PATIENTS WITH RECURRENT CUSHING DISEASE: A CASE SERIES 61
Totale 10.760
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.421
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.549 0 0 205 319 329 358 260 190 290 147 379 72
2020/20211.410 71 139 91 140 96 26 163 72 234 63 152 163
2021/20221.492 42 325 35 48 87 63 64 67 151 197 109 304
2022/20231.854 234 265 35 179 233 304 133 130 224 15 77 25
2023/2024707 42 155 45 53 44 173 40 57 3 8 10 77
2024/2025325 76 102 147 0 0 0 0 0 0 0 0 0
Totale 12.678